Loading...

HooXi Network

TSXV:HXI
Snowflake Description

Excellent balance sheet and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
HXI
TSXV
CA$17M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. The last earnings update was 81 days ago. More info.


Add to Portfolio Compare Print
  • HooXi Network has significant price volatility in the past 3 months.
HXI Share Price and Events
7 Day Returns
0%
TSXV:HXI
-1.1%
CA Biotechs
-0.4%
CA Market
1 Year Returns
-63%
TSXV:HXI
-14.4%
CA Biotechs
-1.1%
CA Market
HXI Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
HooXi Network (HXI) 0% -1% - -63% -82.5% -91.1%
CA Biotechs -1.1% -3.9% 3.2% -14.4% -25.7% -47.7%
CA Market -0.4% 3.7% 2.3% -1.1% 20.3% 4.2%
1 Year Return vs Industry and Market
  • HXI underperformed the Biotechs industry which returned -14.4% over the past year.
  • HXI underperformed the Market in Canada which returned -1.1% over the past year.
Price Volatility
HXI
Industry
5yr Volatility vs Market

Value

 Is HooXi Network undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of HooXi Network to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for HooXi Network.

TSXV:HXI Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 14.7%
Perpetual Growth Rate 10-Year CA Government Bond Rate 1.9%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for TSXV:HXI
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year CA Govt Bond Rate 1.9%
Equity Risk Premium S&P Global 8.1%
Biotechs Unlevered Beta Simply Wall St/ S&P Global 1.58
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.58 (1 + (1- 26.5%) (0%))
1.58
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.58
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.95% + (1.58 * 8.05%)
14.67%

Discounted Cash Flow Calculation for TSXV:HXI using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for HooXi Network is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.

TSXV:HXI DCF 1st Stage: Next 5 year cash flow forecast
2019 2020 2021 2022 2023
Levered FCF (CAD, Millions) 1.33 1.58 1.86 2.18 2.53
Source Est @ 20%, capped from 27.02% Est @ 19%, capped from 27.02% Est @ 18%, capped from 27.02% Est @ 17%, capped from 27.02% Est @ 16%, capped from 27.02%
Present Value
Discounted (@ 14.67%)
1.16 1.20 1.23 1.26 1.27
Present value of next 5 years cash flows CA$6.12
TSXV:HXI DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2023 × (1 + g) ÷ (Discount Rate – g)
= CA$2.53 × (1 + 1.95%) ÷ (14.67% – 1.95%)
CA$20.25
Present Value of Terminal Value = Terminal Value ÷ (1 + r)5
= CA$20.25 ÷ (1 + 14.67%)5
CA$10.21
TSXV:HXI Total Equity Value
Calculation Result
Total Equity Value = Present value of next 5 years cash flows + Terminal Value
= CA$6.12 + CA$10.21
CA$16.34
Equity Value per Share
(CAD)
= Total value / Shares Outstanding
= CA$16.34 / 17.13
CA$0.95
TSXV:HXI Discount to Share Price
Calculation Result
Value per share (CAD) From above. CA$0.95
Current discount Discount to share price of CA$1.00
= -1 x (CA$1.00 - CA$0.95) / CA$0.95
-4.8%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of HooXi Network is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for HooXi Network's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are HooXi Network's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
TSXV:HXI PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-09-30) in CAD CA$-0.90
TSXV:HXI Share Price ** TSXV (2019-02-12) in CAD CA$1
North America Biotechs Industry PE Ratio Median Figure of 36 Publicly-Listed Biotechs Companies 21.12x
Canada Market PE Ratio Median Figure of 559 Publicly-Listed Companies 14.87x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of HooXi Network.

TSXV:HXI PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSXV:HXI Share Price ÷ EPS (both in CAD)

= 1 ÷ -0.90

-1.11x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • HooXi Network is loss making, we can't compare its value to the North America Biotechs industry average.
  • HooXi Network is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does HooXi Network's expected growth come at a high price?
Raw Data
TSXV:HXI PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.11x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
North America Biotechs Industry PEG Ratio Median Figure of 28 Publicly-Listed Biotechs Companies 1.84x
Canada Market PEG Ratio Median Figure of 261 Publicly-Listed Companies 0.96x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for HooXi Network, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on HooXi Network's assets?
Raw Data
TSXV:HXI PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-09-30) in CAD CA$0.24
TSXV:HXI Share Price * TSXV (2019-02-12) in CAD CA$1
Canada Biotechs Industry PB Ratio Median Figure of 39 Publicly-Listed Biotechs Companies 5.98x
Canada Market PB Ratio Median Figure of 2,329 Publicly-Listed Companies 1.52x
TSXV:HXI PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSXV:HXI Share Price ÷ Book Value per Share (both in CAD)

= 1 ÷ 0.24

4.16x

* Primary Listing of HooXi Network.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • HooXi Network is good value based on assets compared to the CA Biotechs industry average.
X
Value checks
We assess HooXi Network's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Biotechs industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Biotechs industry average (and greater than 0)? (1 check)
  5. HooXi Network has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is HooXi Network expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as HooXi Network has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
24%
Expected Biotechs industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is HooXi Network expected to grow at an attractive rate?
  • Unable to compare HooXi Network's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare HooXi Network's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare HooXi Network's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
TSXV:HXI Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Biotechs Industry Earnings Growth Rate Market Cap Weighted Average 24%
Canada Biotechs Industry Revenue Growth Rate Market Cap Weighted Average 27%
Canada Market Earnings Growth Rate Market Cap Weighted Average 16.9%
Canada Market Revenue Growth Rate Market Cap Weighted Average 7.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
TSXV:HXI Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
TSXV:HXI Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2018-09-30 -0 -9
2018-06-30 -1 -9
2018-03-31 -1 -1
2017-12-31 -0 -1
2017-09-30 -1 -1
2017-06-30 -1 -1
2017-03-31 -1 -1
2016-12-31 -1 -1
2016-09-30 -0 -1
2016-06-30 -1 -1
2016-03-31 -1 -2
2015-12-31 -2 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if HooXi Network is high growth as no earnings estimate data is available.
  • Unable to determine if HooXi Network is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
TSXV:HXI Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from HooXi Network Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSXV:HXI Past Financials Data
Date (Data in CAD Millions) EPS *
2018-09-30 -0.90
2018-06-30 -1.00
2018-03-31 -0.12
2017-12-31 -0.19
2017-09-30 -0.21
2017-06-30 -0.24
2017-03-31 -0.28
2016-12-31 -0.28
2016-09-30 -0.31
2016-06-30 -0.35
2016-03-31 -0.44
2015-12-31 -0.59

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if HooXi Network will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine HooXi Network's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. HooXi Network's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Pharmaceuticals & Biotech companies here
  3. HooXi Network's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess HooXi Network's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
HooXi Network has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has HooXi Network performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare HooXi Network's growth in the last year to its industry (Biotechs).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • HooXi Network does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare HooXi Network's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare HooXi Network's 1-year growth to the North America Biotechs industry average as it is not currently profitable.
Earnings and Revenue History
HooXi Network's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from HooXi Network Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSXV:HXI Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-09-30 -8.82 0.89 0.06
2018-06-30 -8.95 0.96 0.11
2018-03-31 -1.26 0.73 0.16
2017-12-31 -1.36 0.78 0.21
2017-09-30 -1.31 0.80 0.22
2017-06-30 -1.25 0.75 0.28
2017-03-31 -1.22 0.76 0.31
2016-12-31 -1.00 0.59 0.33
2016-09-30 -1.09 0.58 0.43
2016-06-30 -1.23 0.64 0.51
2016-03-31 -1.56 0.78 0.11
2015-12-31 -2.07 0.94 0.49
2015-09-30 -1.87 1.00 0.26
2015-06-30 -2.14 1.05 0.50
2015-03-31 -2.45 1.10 0.82
2014-12-31 -2.65 1.10 1.01
2014-09-30 -4.02 1.05 1.38
2014-06-30 -3.77 1.11 1.06
2013-06-30 -1.07 0.56 0.52
2012-06-30 -0.84 0.37 0.48

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if HooXi Network has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if HooXi Network has efficiently used its assets last year compared to the North America Biotechs industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if HooXi Network improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess HooXi Network's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Biotechs industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
HooXi Network has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is HooXi Network's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up HooXi Network's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • HooXi Network's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • HooXi Network has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of HooXi Network's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • HooXi Network has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from HooXi Network Company Filings, last reported 4 months ago.

TSXV:HXI Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-09-30 2.59 0.00 0.46
2018-06-30 2.80 0.00 0.17
2018-03-31 8.35 0.68 0.01
2017-12-31 8.68 0.00 0.12
2017-09-30 3.37 0.00 0.02
2017-06-30 3.71 0.00 0.49
2017-03-31 3.53 0.00 0.01
2016-12-31 3.97 0.00 0.23
2016-09-30 0.32 0.00 0.01
2016-06-30 0.60 0.00 0.11
2016-03-31 0.72 0.00 0.02
2015-12-31 0.93 0.00 0.08
2015-09-30 1.31 0.00 0.40
2015-06-30 1.23 0.00 0.49
2015-03-31 1.78 0.00 0.77
2014-12-31 0.68 0.17 0.90
2014-09-30 0.86 0.00 1.03
2014-06-30 1.55 0.00 1.72
2013-06-30 0.54 0.00 0.59
2012-06-30 1.37 0.00 1.31
  • HooXi Network has no debt.
  • HooXi Network had no debt 5 years ago.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • HooXi Network has sufficient cash runway for more than 3 years based on current free cash flow.
  • HooXi Network has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of -47.6% each year.
X
Financial health checks
We assess HooXi Network's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. HooXi Network has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is HooXi Network's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from HooXi Network dividends.
If you bought CA$2,000 of HooXi Network shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate HooXi Network's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate HooXi Network's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
TSXV:HXI Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Global Biotechs Industry Average Dividend Yield Market Cap Weighted Average of 22 Stocks 2.4%
Canada Market Average Dividend Yield Market Cap Weighted Average of 329 Stocks 3.6%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.1%
Canada Bottom 25% Dividend Yield 25th Percentile 2.1%
Canada Top 25% Dividend Yield 75th Percentile 5.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as HooXi Network has not reported any payouts.
  • Unable to verify if HooXi Network's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of HooXi Network's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as HooXi Network has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess HooXi Network's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can HooXi Network afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. HooXi Network has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of HooXi Network's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Avis Zhu
COMPENSATION CA$0
TENURE AS CEO 0.3 years
CEO Bio

Ms. Yun Zhu, also known as Avis, serves as Chief Executive Officer and Director at HooXi Network Inc. since October 9, 2018. Ms. Zhu serves as Chief Marketing Officer of Seven Stars Media Limited. Ms. Zhu has over 20 years of experience in media, public relations and brand management. Prior to joining Seven Stars Media Limited, she served as Vice President of Sun Media Group, Chief Editor for the Chinese version of French Women's magazine Madame Figaro and worked as editor for Figaro Girl. Prior to this, Ms. Zhu served as Chief Editor for iLook Magazine. He serves as CEO at Sun Medical Group since 2016 and served as VP & CMO of Seven Stars Culture Group from 2011 until 2016.

CEO Compensation
  • Insufficient data for Avis to compare compensation growth.
  • Avis's remuneration is lower than average for companies of similar size in Canada.
Management Team Tenure

Average tenure and age of the HooXi Network management team in years:

8.2
Average Tenure
44
Average Age
  • The average tenure for the HooXi Network management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Avis Zhu

TITLE
CEO & Director
TENURE
0.3 yrs

Norm Tsui

TITLE
President & Director
COMPENSATION
CA$135K
AGE
45
TENURE
8.2 yrs

Alan Tam

TITLE
Chief Financial Officer
COMPENSATION
CA$87K
AGE
44
TENURE
9.1 yrs

Michael McNamara

TITLE
Medical Advisor & Director
TENURE
1.2 yrs

Richard Huang

TITLE
Chief Technology Officer
COMPENSATION
CA$83K
AGE
42
TENURE
9.1 yrs

Richard Cook

TITLE
Chief Medical Officer
TENURE
5.2 yrs

Mouane Sengsavang

TITLE
Corporate Secretary
AGE
42

Jasmine Chiu

TITLE
Vice President
AGE
45
TENURE
9.1 yrs

Trish Josephs

TITLE
Business Development Consultant
Board of Directors Tenure

Average tenure and age of the HooXi Network board of directors in years:

1.1
Average Tenure
57
Average Age
  • The average tenure for the HooXi Network board of directors is less than 3 years, this suggests a new board.
Board of Directors

Bruno Wu

TITLE
Chairman of the Board
AGE
52
TENURE
1.1 yrs

Avis Zhu

TITLE
CEO & Director
TENURE
0.3 yrs

Norm Tsui

TITLE
President & Director
COMPENSATION
CA$135K
AGE
45
TENURE
8.2 yrs

Don Romaniuk

TITLE
Independent Director
AGE
62
TENURE
8.2 yrs

Dennis Nerland

TITLE
Independent Director
AGE
65
TENURE
8.2 yrs

Michael McNamara

TITLE
Medical Advisor & Director
TENURE
0.9 yrs

Bing Wu

TITLE
Independent Director
TENURE
0.3 yrs
Who owns this company?
Recent Insider Trading
  • Information is not available.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
15. Feb 19 Sell Norman Tsui Individual 28. Jan 19 28. Jan 19 -2,000 CA$1.12 CA$-2,240
23. Jan 19 Buy Norman Tsui Individual 02. Jan 19 02. Jan 19 2,000 CA$0.86 CA$1,720
26. Apr 18 Sell Shui Tam Individual 26. Apr 18 26. Apr 18 -6,667 CA$2.02 CA$-13,500
19. Mar 18 Sell Shui Tam Individual 19. Mar 18 19. Mar 18 -4,000 CA$2.18 CA$-8,700
X
Management checks
We assess HooXi Network's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. HooXi Network has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Do Institutions Own Liberty Biopharma Inc (CVE:HXI) Shares?

A look at the shareholders of Liberty Biopharma Inc (CVE:HXI) can tell us which group is most powerful. … With a market capitalization of CA$9.7m, Liberty Biopharma is a small cap stock, so it might not be well known by many institutional investors. … Check out our latest analysis for Liberty Biopharma

Simply Wall St -

Company Info

Map
Description

Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada.

Details
Name: HooXi Network Inc.
HXI
Exchange: TSXV
Founded:
CA$17,128,629
17,128,629
Website: http://www.libertybiopharma.com
Address: HooXi Network Inc.
2270 – 8788 McKim Way,
Richmond,
British Columbia, V6X 4E2,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSXV HXI Common Shares TSX Venture Exchange CA CAD 18. Dec 2013
Number of employees
Current staff
Staff numbers
0
HooXi Network employees.
Industry
Biotechnology
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/02/18 03:18
End of day share price update: 2019/02/12 00:00
Last earnings filing: 2018/11/29
Last earnings reported: 2018/09/30
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.